VALEANT PHARMACEUTICALS INTL
COM · CUSIP 91911K102
2
institutional holders
1.2m
shares reported held*
$34.5mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $29.92.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| Bruce & Co., Inc. 6.66% of their portfolio | 1.1m $34.1m | — |
| LeJeune Puetz Investment Counsel LLC 0.18% of their portfolio | 12.8k $381.0k | — |